JP7884275B2 - 二環式化合物及び疾患の治療のためのその使用 - Google Patents
二環式化合物及び疾患の治療のためのその使用Info
- Publication number
- JP7884275B2 JP7884275B2 JP2023551946A JP2023551946A JP7884275B2 JP 7884275 B2 JP7884275 B2 JP 7884275B2 JP 2023551946 A JP2023551946 A JP 2023551946A JP 2023551946 A JP2023551946 A JP 2023551946A JP 7884275 B2 JP7884275 B2 JP 7884275B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- mmol
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108660P | 2020-11-02 | 2020-11-02 | |
| US63/108,660 | 2020-11-02 | ||
| PCT/US2021/057563 WO2022094400A1 (en) | 2020-11-02 | 2021-11-01 | Bicyclic compounds and uses thereof for the treatment of diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023550543A JP2023550543A (ja) | 2023-12-01 |
| JP2023550543A5 JP2023550543A5 (cg-RX-API-DMAC7.html) | 2024-11-06 |
| JP7884275B2 true JP7884275B2 (ja) | 2026-07-03 |
Family
ID=81384389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551946A Active JP7884275B2 (ja) | 2020-11-02 | 2021-11-01 | 二環式化合物及び疾患の治療のためのその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240025903A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4236944A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7884275B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230104191A (cg-RX-API-DMAC7.html) |
| CN (2) | CN116568301A (cg-RX-API-DMAC7.html) |
| AR (1) | AR124637A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021371026A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196582A1 (cg-RX-API-DMAC7.html) |
| CL (2) | CL2023001195A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302465A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004942A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI918751B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022094400A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL313039A (en) * | 2021-12-17 | 2024-07-01 | Athira Pharma Inc | Uses of bicyclic compounds for the treatment of diseases |
| KR20250005323A (ko) * | 2022-05-04 | 2025-01-09 | 아티라 파마, 인코포레이티드 | 신경병증을 치료하는 방법 |
| US20250275976A1 (en) * | 2022-05-04 | 2025-09-04 | Athira Pharma, Inc. | Methods of Treating Neuroinflammatory Conditions |
| JP2025538382A (ja) | 2022-11-18 | 2025-11-28 | アティラ・ファーマ・インコーポレイテッド | 炎症病態を治療する方法 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503352A (ja) | 1999-06-25 | 2003-01-28 | モレキュメティックス リミテッド | 逆ターン模倣物およびそれに関する方法 |
| WO2004035587A1 (en) | 2002-10-17 | 2004-04-29 | Myriad Genetics, Inc. | Reverse-turn mimetics and composition and methods relating thereto |
| JP2006513221A (ja) | 2002-12-21 | 2006-04-20 | アンジオン バイオメディカ コーポレイション | 肝細胞増殖因子(分散因子)活性のピラゾール誘導体モジュレーター |
| JP2008514636A (ja) | 2004-09-28 | 2008-05-08 | アンジオン バイオメディカ コーポレイション | サイトカイン活性の低分子モジュレーター |
| JP2012505153A (ja) | 2008-10-14 | 2012-03-01 | PRISM BioLab株式会社 | アルファへリックスミメティック及び関連の方法 |
| WO2014025832A1 (en) | 2012-08-06 | 2014-02-13 | University Of Southern California | Wnt modulators for the protection, mitigation and treatment of radiation injury |
| WO2017047762A1 (ja) | 2015-09-18 | 2017-03-23 | 国立大学法人鳥取大学 | 低分子化合物による癌と線維化の抑制と再生促進の効果 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7879898B1 (en) * | 2006-02-14 | 2011-02-01 | Angion Biomedica Corp. | Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease |
| EP1947085A1 (en) * | 2007-01-19 | 2008-07-23 | Laboratorios del Dr. Esteve S.A. | Substituted indole sulfonamide compounds, their preparation and use as medicaments |
-
2021
- 2021-11-01 AU AU2021371026A patent/AU2021371026A1/en active Pending
- 2021-11-01 EP EP21887720.7A patent/EP4236944A4/en active Pending
- 2021-11-01 US US18/032,918 patent/US20240025903A1/en active Pending
- 2021-11-01 MX MX2023004942A patent/MX2023004942A/es unknown
- 2021-11-01 TW TW110140600A patent/TWI918751B/zh active
- 2021-11-01 JP JP2023551946A patent/JP7884275B2/ja active Active
- 2021-11-01 IL IL302465A patent/IL302465A/en unknown
- 2021-11-01 AR ARP210103033A patent/AR124637A1/es unknown
- 2021-11-01 KR KR1020237018061A patent/KR20230104191A/ko active Pending
- 2021-11-01 CN CN202180079749.8A patent/CN116568301A/zh active Pending
- 2021-11-01 CA CA3196582A patent/CA3196582A1/en active Pending
- 2021-11-01 WO PCT/US2021/057563 patent/WO2022094400A1/en not_active Ceased
- 2021-11-01 CN CN202411623883.1A patent/CN119684295A/zh active Pending
-
2023
- 2023-04-26 CL CL2023001195A patent/CL2023001195A1/es unknown
-
2024
- 2024-02-02 CL CL2024000340A patent/CL2024000340A1/es unknown
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503352A (ja) | 1999-06-25 | 2003-01-28 | モレキュメティックス リミテッド | 逆ターン模倣物およびそれに関する方法 |
| WO2004035587A1 (en) | 2002-10-17 | 2004-04-29 | Myriad Genetics, Inc. | Reverse-turn mimetics and composition and methods relating thereto |
| JP2006513221A (ja) | 2002-12-21 | 2006-04-20 | アンジオン バイオメディカ コーポレイション | 肝細胞増殖因子(分散因子)活性のピラゾール誘導体モジュレーター |
| JP2008514636A (ja) | 2004-09-28 | 2008-05-08 | アンジオン バイオメディカ コーポレイション | サイトカイン活性の低分子モジュレーター |
| JP2012505153A (ja) | 2008-10-14 | 2012-03-01 | PRISM BioLab株式会社 | アルファへリックスミメティック及び関連の方法 |
| WO2014025832A1 (en) | 2012-08-06 | 2014-02-13 | University Of Southern California | Wnt modulators for the protection, mitigation and treatment of radiation injury |
| WO2017047762A1 (ja) | 2015-09-18 | 2017-03-23 | 国立大学法人鳥取大学 | 低分子化合物による癌と線維化の抑制と再生促進の効果 |
Non-Patent Citations (1)
| Title |
|---|
| JIN-WOONG, Kim et al.,Solution-phase Synthesis and Preliminary Evaluation of 1,6,8-Trisubstituted Tetrahydro-2H-pyrazino[1,2-a]pyrimidin-4,7-dione Derivatives as a NF-κB Inhibitor,Bull. Korean Chem. Soc.,2006年,Vol.27, No.12,p.2087-2090 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4236944A1 (en) | 2023-09-06 |
| TWI918751B (zh) | 2026-03-21 |
| CL2024000340A1 (es) | 2024-08-16 |
| CN116568301A (zh) | 2023-08-08 |
| US20240025903A1 (en) | 2024-01-25 |
| CN119684295A (zh) | 2025-03-25 |
| CA3196582A1 (en) | 2022-05-05 |
| AU2021371026A1 (en) | 2023-06-15 |
| JP2023550543A (ja) | 2023-12-01 |
| AU2021371026A9 (en) | 2024-04-18 |
| KR20230104191A (ko) | 2023-07-07 |
| AR124637A1 (es) | 2023-04-19 |
| IL302465A (en) | 2023-06-01 |
| CL2023001195A1 (es) | 2023-10-20 |
| TW202233622A (zh) | 2022-09-01 |
| MX2023004942A (es) | 2023-07-06 |
| EP4236944A4 (en) | 2024-09-04 |
| WO2022094400A1 (en) | 2022-05-05 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230530 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20230530 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241028 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241028 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250825 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250902 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251016 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260227 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260519 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260616 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7884275 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |